Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series

(1) Background: direct-acting antivirals (DAA) are the current standard of care for chronic hepatitis C. Oncologic patients remain among the most difficult-to-treat subgroups of hepatitis C virus (HCV)-infected patients due to their clinical frailty and complex therapeutic protocols received. (2) Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Patauner, Fabian, Stanzione, Maria, Stornaiuolo, Gianfranca, Martone, Veronica, Palladino, Roberta, Coppola, Nicola, Durante-Mangoni, Emanuele, Zampino, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414735/
https://www.ncbi.nlm.nih.gov/pubmed/36014981
http://dx.doi.org/10.3390/pathogens11080860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414735/
https://www.ncbi.nlm.nih.gov/pubmed/36014981
http://dx.doi.org/10.3390/pathogens11080860

Ejemplares similares